Notes from the Field: Pan-Resistant New Delhi Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae - Washoe County, Nevada, 2016.
作者信息
Chen Lei, Todd Randall, Kiehlbauch Julia, Walters Maroya, Kallen Alexander
出版信息
MMWR Morb Mortal Wkly Rep. 2017 Jan 13;66(1):33. doi: 10.15585/mmwr.mm6601a7.
Abstract
摘要
相似文献
1
Notes from the Field: Pan-Resistant New Delhi Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae - Washoe County, Nevada, 2016.实地记录：产泛耐药新德里金属β-内酰胺酶的肺炎克雷伯菌——内华达州瓦肖县，2016年
MMWR Morb Mortal Wkly Rep. 2017 Jan 13;66(1):33. doi: 10.15585/mmwr.mm6601a7.
2
Klebsiella pneumoniae co-producing NDM-5 and OXA-181 carbapenemases, South Korea.韩国发现产NDM-5和OXA-181碳青霉烯酶的肺炎克雷伯菌。
Emerg Infect Dis. 2015 Jun;21(6):1088-9. doi: 10.3201/eid2106.150048.
3
Comparative in vitro killing of carbapenems and aztreonam against Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.碳青霉烯类药物和氨曲南对产VIM-1金属β-内酰胺酶肺炎克雷伯菌的体外杀菌效果比较
Int J Antimicrob Agents. 2007 Mar;29(3):360-2. doi: 10.1016/j.ijantimicag.2006.11.004. Epub 2007 Jan 12.
4
Successful treatment of NDM-1 Klebsiella pneumoniae bacteraemia in a neutropenic patient.成功治疗一名中性粒细胞减少患者的NDM-1肺炎克雷伯菌菌血症。
Scand J Infect Dis. 2012 Apr;44(4):312-4. doi: 10.3109/00365548.2011.633549. Epub 2011 Nov 29.
5
First isolation of metallo-beta-lactamase-producing multiresistant Klebsiella pneumoniae from a patient in Brazil.首次从巴西一名患者体内分离出产金属β-内酰胺酶的多重耐药肺炎克雷伯菌。
J Clin Microbiol. 2005 Jan;43(1):516-9. doi: 10.1128/JCM.43.1.516-519.2005.
6
First Report of a Verona Integron-Encoded Metallo-β-Lactamase-Producing Klebsiella pneumoniae Infection in a Child in the United States.美国一名儿童感染产 Verona 整合子编码金属β-内酰胺酶肺炎克雷伯菌的首例报告。
J Pediatric Infect Dis Soc. 2016 Sep;5(3):e24-7. doi: 10.1093/jpids/piw025. Epub 2016 May 4.
7
New Delhi metallo-β-lactamase and multidrug resistance: a global SOS?新德里金属β-内酰胺酶与多重耐药性：全球发出的紧急求救信号？
Clin Infect Dis. 2011 Feb 15;52(4):485-7. doi: 10.1093/cid/ciq179.
8
[Endocarditis caused by extended spectrum beta lactamase producing Klebsiella].产超广谱β-内酰胺酶肺炎克雷伯菌所致的心内膜炎
Rev Clin Esp. 2011 Mar;211(3):163-4. doi: 10.1016/j.rce.2010.06.016.
9
First report of a clinical isolate of New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae in Brazil.巴西首例产新德里金属β-内酰胺酶肺炎克雷伯菌临床分离株的报告
J Hosp Infect. 2016 Sep;94(1):73-4. doi: 10.1016/j.jhin.2016.05.019. Epub 2016 Jun 4.
引用本文的文献
1
Rapid emergence of resistance to broad-spectrum direct antimicrobial activity of avibactam.阿维巴坦对广谱直接抗菌活性的耐药性迅速出现。
Microbiol Spectr. 2025 Jun 12:e0324124. doi: 10.1128/spectrum.03241-24.
2
Co-selection for antibiotic resistance by environmental contaminants.环境污染物对抗生素耐药性的共同选择
NPJ Antimicrob Resist. 2024 Apr 1;2(1):9. doi: 10.1038/s44259-024-00026-7.
3
Rapid Emergence of Resistance to Broad-Spectrum Direct Antimicrobial Activity of Avibactam.阿维巴坦对广谱直接抗菌活性的耐药性迅速出现。
bioRxiv. 2024 Sep 25:2024.09.25.615047. doi: 10.1101/2024.09.25.615047.
4
The multifaceted roles of phosphoethanolamine-modified lipopolysaccharides: from stress response and virulence to cationic antimicrobial resistance.磷酸乙醇胺修饰的脂多糖的多方面作用：从应激反应、毒力到阳离子抗菌耐药性
Microbiol Mol Biol Rev. 2024 Dec 18;88(4):e0019323. doi: 10.1128/mmbr.00193-23. Epub 2024 Oct 9.
5
Impact of nitric oxide donors on capsule, biofilm and resistance profiles of Klebsiella pneumoniae.一氧化氮供体对肺炎克雷伯菌囊泡、生物膜和耐药谱的影响。
Int J Antimicrob Agents. 2024 Nov;64(5):107339. doi: 10.1016/j.ijantimicag.2024.107339. Epub 2024 Sep 18.
6
Genomic Characterization of Multidrug-Resistant Enterobacteriaceae Clinical Isolates from Southern Thailand Hospitals: Unraveling Antimicrobial Resistance and Virulence Mechanisms.泰国南部医院耐多药肠杆菌科临床分离株的基因组特征：揭示抗菌耐药性和毒力机制
Antibiotics (Basel). 2024 Jun 6;13(6):531. doi: 10.3390/antibiotics13060531.
7
A Case of New Delhi Metallo-ß-Lactamase-Producing Enterobacter and a Review of Cases in the United States From January 2009 to September 2022.一例产新德里金属β-内酰胺酶的肠杆菌病例及2009年1月至2022年9月美国病例回顾
Cureus. 2024 May 13;16(5):e60200. doi: 10.7759/cureus.60200. eCollection 2024 May.
8
Exploring Structure-Activity Relationships of Niclosamide-Based Colistin Potentiators in Colistin-Resistant Gram-Negative Bacteria.探索基于氯硝柳胺的黏菌素增效剂在耐黏菌素革兰氏阴性菌中的构效关系。
Antibiotics (Basel). 2024 Jan 3;13(1):43. doi: 10.3390/antibiotics13010043.
9
A mechanism-based pathway toward administering highly active N-phage cocktails.一种基于机制的施用高活性N噬菌体鸡尾酒疗法的途径。
Front Microbiol. 2023 Nov 15;14:1292618. doi: 10.3389/fmicb.2023.1292618. eCollection 2023.
10
Studying the Human Microbiota: Advances in Understanding the Fundamentals, Origin, and Evolution of Biological Timekeeping.研究人类微生物组：对生物钟的基本原理、起源和进化的理解进展。
Int J Mol Sci. 2023 Nov 10;24(22):16169. doi: 10.3390/ijms242216169.
本文引用的文献
1
Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013.2012 - 2013年美国7个社区耐碳青霉烯类肠杆菌科细菌的流行病学
JAMA. 2015 Oct 13;314(14):1479-87. doi: 10.1001/jama.2015.12480.
Zotero 插件